112
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy of Oxymetholone in Severe and Nonsevere Acquired Aplastic Anemia: A Propensity Score Matching Analysis

ORCID Icon & ORCID Icon
Pages 753-761 | Received 10 Aug 2022, Accepted 18 Nov 2022, Published online: 07 Dec 2022

References

  • Issaragrisil S, Kaufman DW, Anderson T, et al. The epidemiology of aplastic anemia in Thailand. Blood. 2006;107(4):1299–1307. doi:10.1182/blood-2005-01-0161
  • Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172(2):187–207. doi:10.1111/bjh.13853
  • Townsley DM, Scheinberg P, Winkler T, et al. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med. 2017;376(16):1540–1550. doi:10.1056/NEJMoa1613878
  • Uaprasert N, Chansung K, Pongtanakul B, et al. Guideline for diagnosis and management of aplastic anemia in Thailand 2020. J Hematol Transfus Med. 2020;30(4):405–414.
  • Bär C, Huber N, Beier F, et al. Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres. Haematologica. 2015;100(10):1267–1274. doi:10.3324/haematol.2015.129239
  • Calado RT, Yewdell WT, Wilkerson KL, et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood. 2009;114(11):2236–2243. doi:10.1182/blood-2008-09-178871
  • Gutiérrez-Serdán R, López-Karpovitch X. Acquired aplastic anemia: a demographic, clinical, and therapeutic survey of a single institution in Mexico City. Rev Hematol Mex. 2016;17(2):81–89.
  • Pizzuto J, Conte G, Sinco A, et al. Use of androgens in acquired aplastic anaemia. Relation of response to aetiology and severity. Acta Haematol. 1980;64(1):18–24. doi:10.1159/000207205
  • Gafter-Gvili A, Ram R, Gurion R, et al. ATG plus cyclosporine reduces all-cause mortality in patients with severe aplastic anemia-systematic review and meta-analysis. Acta Haematol. 2008;120(4):237–243. doi:10.1159/000203403
  • Ellis RJ, Kahn Q, Skikne BS, et al. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution. Mil Med. 2002;167(7):541–545.
  • Paquette RL, Tebyni N, Frane M. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood. 1995;85(1):283–290. doi:10.1182/blood.V85.1.283.bloodjournal851283
  • Passweg JR, Marsh JC. Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation. Hematology Am Soc Hematol Educ Program. 2010;2010:36–42. doi:10.1182/asheducation-2010.1.36
  • Valdez JM, Scheinberg P, Nunez O, et al. Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. Clin Infect Dis. 2011;52(6):726–735. doi:10.1093/cid/ciq245
  • Argote VEF, Peñafiel COR, Sánchez M, et al. Androgen treatment for acquired aplastic anemia in Mexican adults. Blood. 2008;112(11):1046. doi:10.1182/blood.V112.11.1046.1046
  • Jaime-Perez JC, Colunga-Pedraza PR, Gomez-Ramirez CD, et al. Danazol as first-line therapy for aplastic anemia. Ann Hematol. 2011;90(5):523–527. doi:10.1007/s00277-011-1163-x
  • Mir MA, Delamore IW. Oxymetholone in aplastic anaemia. Postgrad Med J. 1974;50(581):166–171. doi:10.1136/pgmj.50.581.166
  • Dezern AE, Brodsky RA. Clinical management of aplastic anemia. Expert Rev Hematol. 2011;4(2):221–230. doi:10.1586/ehm.11.11